EKF Diagnostics Holdings PLC Notice of Results (6964J)

TIDMEKF

RNS Number : 6964J

EKF Diagnostics Holdings PLC

21 August 2019

EKF Diagnostics Holdings plc

("EKF", the "Company")

Notice of results

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it will release its interim results for the six months ended 30 June 2019 on Tuesday 10 September 2019.

Investor briefing

A briefing for all investors will take place on Tuesday 10 September 2019 at the Brand Exchange, 3 Birchin Lane, EC3V 9BW from 5.30pm for a 5.45pm start and will be followed by refreshments. If you would like to register, please contact Walbrook PR on 020 7933 8780 or email ekf@walbrookpr.com

Enquiries:

 
     EKF Diagnostics Holdings plc                            www.ekfdiagnostics.com 
     Christopher Mills, Non-Executive Chairman                   Tel: 029 2071 0570 
     Julian Baines, CEO 
     Richard Evans, FD & COO 
 
     N+1 Singer (Nomad & Broker)                                 Tel: 020 7496 3000 
     Aubrey Powell / Lauren Kettle / George Tzimas 
      (Corporate Finance) 
      Tom Salvesen (Corporate Broking) 
 
     Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com 
     Paul McManus/ Lianne Cawthorne                      Mob: 07980 541 893 / 07584 
                                                                            391 303

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORDMGZRVGKGLZM

(END) Dow Jones Newswires

August 21, 2019 02:00 ET (06:00 GMT)

Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2024 to May 2024